CHARLESTON, S.C., & MISGAV, Israel--(BUSINESS WIRE)--ApiFix® Ltd. announced today that the company is helping the parents of children from Australia, Canada and the United States who have Adolescent Idiopathic Scoliosis (AIS) to identify spine surgeons in Europe and Israel who have adopted the ApiFix® system to treat AIS. ApiFix is approved for sale in Europe and Israel.
“There is an acute need for an alternative to today’s standard for scoliosis correction in children and adolescents, which is the most aggressive and invasive procedure in spine surgery,” said Uri Arnin, CEO. “Therefore we are grateful to be able to introduce the parents of children with AIS to spine surgeons who have adopted ApiFix and are treating patients in countries where ApiFix is now approved for use.”
“The scoliosis curve correction at up to three years follow-up is substantial for the children who have been treated with the less-invasive ApiFix procedure. We are extremely proud to be able to offer this innovation to children and adolescents from 10 to 17 years of age,” said Prof. Dr. Yizhar Floman.
A clinical study of The ApiFix® System led by Prof. Dr. Floman, past President of the Israel Spine Society, was published this year in the peer-reviewed medical journal Scoliosis, which concluded that “there are many drawbacks to the current gold standard of AIS surgery, which are almost nonexistent with the use of ApiFix.”
Now, there’s the ApiFix system,” approved for sale in Europe and designed to be a new standard for correcting scoliosis in children and adolescents.
ApiFix® is a commercial-stage company that has developed the CE-marked ApiFix® System — a non-fusion minimally invasive treatment alternative for Adolescent Idiopathic Scoliosis (AIS). Scoliosis surgery is the most invasive procedure in spine. The average procedure fuses 10 vertebrae together using 20 screws, resulting in significant and permanent loss of spine mobility.
(For detailed clinical data, contact ApiFix CEO Uri Arnin: email@example.com.)